Health Condition 1: F419- Anxiety disorder, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Mankind pharma LTD
Eligibility
Inclusion criteria
Inclusion criteria: 1. Males and females 18 years old and above, diagnosed with type 2 diabetes by a healthcare provider. 2. Duration of type 2 diabetes for one year or longer. 3. Under medical care for diabetes treatment according to medical documents. 4. Ability to understand the questions. 5. Willingness to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Physical and/or mental conditions that interfere with participation. 2. Type 1 diabetes 3. Gestational diabetes 4. Connective Tissue Disease (CTD) patients 5. Patients on Corticosteroid therapy 6. Patients already taking antidepressants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aims to analyze various components of depression associated as comorbidity in T2DM patients.Timepoint: Data Collection 2 WEEKS TO 24 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic details , and evaluate the burden of diabetes and depression as comorbid with the support of PH9 QuestionnaireTimepoint: 3 Months | — |
Countries
India
Contacts
Public ContactDrMerin Dickson
De Sousa Foundation
Outcome results
None listed